Identification of a novel protein binding to hepatitis C virus core protein

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 7, 2009, Pages 1300-1304

  Chen, Yun Ru ^a   Chen, Tian Yan ^a   Zhang, Shu Lin ^a   Lin, Shu Mei ^a   Zhao, Ying Ren ^a   Ye, Feng ^a   Zhang, Xi ^a   Shi, Lei ^a   Dang, Shuang Suo ^a   Liu, Min ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Core protein; HCV; Protein protein interaction; Yeast two hybrid

Indexed keywords

ASPARTOACYLASE; ASPARTOACYLASE 3; COMPLEMENTARY DNA; CORE PROTEIN; GREEN FLUORESCENT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOPLASM; FLUORESCENCE MICROSCOPY; HEPATITIS C VIRUS; HYBRID CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; VIRUS VIRULENCE; YEAST;

EID: 68749108636     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.05846.x     Document Type: Article

References (23)

1. The Global Burden of hepatitis C Working Group. Global burden of disease (GBD) for hepatitis C. J. Clin. Pharmacol. 2004 20 9.
2. Rhoads J. Natural history and epidemiology of hepatitis C. J. Assoc. Nurses AIDS Care 2003 14 : 18 25.
3. Choo QL, Kuo G, Weiner AJ et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989 244 : 359 62.
4. McLauchlan J. Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes. J. Viral Hepat. 2000 7 : 2 14.
5. Ray RB, Lagging LM, Meyer K et al. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res. 1995 37 : 209 20.
6. Matsumoto M, Hsieh TY, Zhu N et al. Hepatitis C virus core protein interacts with cytoplasmic tail of lymphotoxin-β recepor. J. Virol. 1997 71 : 1301 9.
7. Zhu N, Khosnan A, Schneider R et al. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J. Virol. 1998 72 : 3691 7.
8. Li K, Wang L, Cheng J et al. Screening and cloning gene of hepatocyte protein interacting with hepatitis C virus core protein. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2002 16 : 351 3.
9. Wang L, Cheng J, Li K et al. Identification and evaluation promoter sequence and the transcription activation of Hcbp6 interaction with core protein of hepatitis C virus. Zhonghua Gan Zang Bing Za Zhi 2006 14 : 81 5.
10. Jun C, Ke L, Yan L et al. Effects of HCBP6 protein on transactivating function of HCV core protein. World Chin. J. Digestol. 2004 12 : 809 12.
11. Ross MT, Grafham DV, Coffey AJ et al. The DNA sequence of the human X chromosome. Nature 2005 434 : 325 37.
12. Yue L, Qi W, Jun C et al. Prokaryotic expression, purification, and production of polyclonal antibody against HCBP12. Chin. J. Clin. Pharmacol. Ther. 2008 13 : 425 30.
13. Lin B, White JT, Ferguson C et al. Prostate Short-Chain Dehydrogenase Reductase 1 (PSDR1): a new member of the short-chain steroid dehydrogenase/reductase family highly expressed in normal and neoplastic prostate epithelium1. Cancer Res. 2001 61 : 1611 18.
14. Kedishvili YN, Chumakova OV, Chetyrkin SV et al. Evidence that the human gene for Prostate Short-chain Dehydrogenase/Reductase (PSDR1) Encodes a Novel Retinal Reductase (RalR1). J. Biol. Chem. 2002 9 : 28909 15.
15. Belyaeva OV, Stetsenko AV, Nelson P et al. Properties of short-chain dehydrogenase/reductase RalR1: characterization of purified enzyme, its orientation in the microsomal membrane, and distribution in human tissues and cell lines. Biochemistry 2003 42 : 14838 45.
16. Moore S, Pritchard C, Lin B et al. Isolation and characterization of the murine prostate short-chain dehydrogenase/reductase 1 (Psdr1) gene, a new member of the short-chain steroid dehydrogenase/reductase family. Gene 2002 293 : 149 60.
17. Perrier J, Durand A, Giardina T et al. Catabolism of intracellular N-terminal acetylated proteins: involvement of acylpeptide hydrolase and acylase. Biochimie 2005 87 : 673 85.
18. Hershfield JR, Madhavarao CN, Moffett JR et al. Aspartoacylase is a regulated nuclear-cytoplasmic enzyme. FASEB J 2006 20 : 1485 94.
19. Newman D, Abuladze N, Scholz K et al. Specificity of aminoacylase III-mediated deacetylation of mercapturic acids. Drug Metab. Dispos. 2007 35 : 43 50.
20. Ryazantsev V, Motemoturu S, Sassani S et al. Structural characterization,tissue distribution, and functional expression of murine aminoacylase III. Am. J. Physiol. Cell Physiol. 2004 286 : 848 56.
21. Lauterburg BH, Corcoran GB, Mitchell JR et al. Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo. J. Clin. Invest. 1983 71 : 980 91.
22. Thor H, Molde'us P, Orrenius S et al. Metabolic activation and hepatotoxicity. Effect of cysteine, N-acetylcysteine, and methionine on glutathione biosynthesis and bromobenzene toxicity in isolated rat hepatocytes. Arch. Biochem. Biophys. 1979 192 : 405 13.
23. Kashireddy PV, Rao MS. Lack of peroxisome proliferator-activated receptor alpha in mice enhances methionine and choline deficient diet-induced steatohepatitis. Hepatol. Res. 2004 30 : 104 10.